Dagmar Dilloo

6.4k citations

92 papers · 4.7k indexed · 1 hit paper · h-index 29

Impact in

Genetics top 0.5%
- Mesenchymal stem cell research
- Virus-based gene therapy research
Hematology top 1%
- Hematopoietic Stem Cell Transplantation

Papers in

Hematology 37
- Hematopoietic Stem Cell Transplantation 28
- Acute Myeloid Leukemia Research 12
Genetics 15
- Virus-based gene therapy research 11

Co-authors: Roland Meisel U. Göbel Walter Däubener Andree Zibert M. D. Laryea Helmut Hanenberg Malcolm K. Brenner Xiang Xiao
Journals: Blood (10 papers)Bone Marrow Transplantation (7 papers)British Journal of Haematology (5 papers)Oncotarget (3 papers)Journal of Clinical Oncology (3 papers)
Partner nations: Germany United States Austria

In The Last Decade

Dagmar Dilloo

91 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation 2004 · 1.3k citations

Peers

Countries citing papers authored by Dagmar Dilloo

Since Specialization

Citations

This map shows the geographic impact of Dagmar Dilloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Dilloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Dilloo more than expected).

Fields of papers citing papers by Dagmar Dilloo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Dilloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Dilloo. The network helps show where Dagmar Dilloo may publish in the future.

Co-authors

The 25 scholars most cited alongside Dagmar Dilloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dagmar Dilloo Line = papers co-authored together Dagmar Dilloo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors Journal of Cancer Research and Clinical Oncology ·Stefan Schönberger, Mahsa Mohseni, Jörg Ellinger, 和美篠崎, Martina Becker, Alexander Claviez, 根本尚子, Bárbara Hermes, Pablo Hernáiz Driever, Norbert Jorch, Melchior Lauten, Marcus Mehlitz, Niklas Schäfer, S. R. Yudhika, Dominik T. Schneider, Anja Troeger, Gabriele Calaminus, Dagmar Dilloo	2022	14
2	Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines Cancers ·Stefan Schönberger, Claudia Nutz, Daniel Nettersheim, Hubert Schorle, Anna Casati, Rogerio B. Craveiro, Mahsa Mohseni, Gabriele Calaminus, Dagmar Dilloo	2020	5
3	The FDA approved PI3K inhibitor GDC‐0941 enhances in vitro the anti‐neoplastic efficacy of Axitinib against c‐myc‐amplified high‐risk medulloblastoma Journal of Cellular and Molecular Medicine ·Michael Ehrhardt, Rogerio B. Craveiro, Julia Velz, G. Rutkowski, Anna Casati, Stefan Schönberger, Torsten Pietsch, Dagmar Dilloo	2018	13
4	Brentuximab vedotin exerts profound antiproliferative and pro‐apoptotic efficacy in CD30‐positive as well as cocultured CD30‐negative germ cell tumour cell lines Journal of Cellular and Molecular Medicine ·Stefan Schönberger, Lars Helleberg, Mohamad Nizam Nazarudin, Daniel Nettersheim, Hubert Schorle, Dominik T. Schneider, Anna Casati, Rogerio B. Craveiro, Gabriele Calaminus, Dagmar Dilloo	2017	20
5	MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: Case report and review of 68 cases in the literature Pediatric Transplantation ·C.D. Padula, Sonja Gudowius, Karen Beltz, Shibdawa Am, Oliver Feyen, Anja Troeger, U. Göbel, H.-J. Laws, Olga Danallara Borrego Gastelum, Roland Meisel, Dagmar Dilloo, Tim Niehues	2010	12
6	The CD70/CD27 Pathway Is Critical for Stimulation of an Effective Cytotoxic T Cell Response against B Cell Precursor Acute Lymphoblastic Leukemia The Journal of Immunology ·T GREENWAY, Birgit Ackermann, Andree Zibert, Roland Meisel, C.D. Padula, Gritta Janka‐Schaub, Ulrich Goebel, Anja Troeger, Dagmar Dilloo	2009	26
7	Reduced Expression and Defective Modulation of TNF Receptor/Ligand Family Molecules on proB-ALL Blasts Klinische Pädiatrie ·Anja Troeger, T GREENWAY, Gabriele Escherich, C.D. Padula, Helmut Hanenberg, Gritta Janka‐Schaub, U. Göbel, Birgit Ackermann, Dagmar Dilloo	2008	2
8	Comparable Long-Term Survival after Bone Marrow versus Peripheral Blood Progenitor Cell Transplantation from Matched Unrelated Donors in Children with Hematologic Malignancies Biology of Blood and Marrow Transplantation ·Roland Meisel, Hans‐Jürgen Laws, Stefan Balzer, Benedikt Bernbeck, Christof M. Kramm, Stefan Schönberger, 山本健次郎, V. S. Vikhorev, Monika Schmitz, Johannes Fischer, U. Göbel, Jürgen Enczmann, Dagmar Dilloo	2007	30
9	Serial Intense Chemotherapy Combining Topotecan, Etoposide, Carboplatin and Cyclophosphamide (TECC) Followed by Autologous Hematopoietic Stem Cell Support in Patients with High Risk Soft Tissue Sarcoma (STS) Klinische Pädiatrie ·Benedikt Bernbeck, 梁成秀, Roland Meisel, Anja Troeger, Stefan Schönberger, H.‐J. Laws, Christof M. Kramm, R. Wessalowski, E. Koscielniak, Dagmar Dilloo, U. Göbel	2007	4
10	Role of Survivin Splice Variants in Pediatric Acute Precursor B Lymphoblastic Leukemia Klinische Pädiatrie ·Martin Stromberger, C.D. Padula, Csaba Mahotka, Nils Wethkamp, Hermann Lion, Hans-Juergen Laws, Gabriele Escherich, Gritta Janka‐Schaub, Ulrike Göbel, Dagmar Dilloo	2007	12
11	Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia Bone Marrow Transplantation ·Barbara Meissner, Arndt Borkhardt, Dagmar Dilloo, А. В. Сухов, W Friedrich, Rupert Handgretinger, Christina Peters, André Schrauder, Friedhelm R. Schuster, Josef Vormoor, Britta Maecker, Karl‐Walter Sykora, F Zintl, Karl Welte, Martin G. Sauer	2007	24
12	Immunotherapy in allogeneic hematopoietic stem cell transplantation – not just a case for effector cells Bone Marrow Transplantation ·Anja Troeger, Roland Meisel, Tassilo Moritz, Dagmar Dilloo	2005	11
13	Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia Leukemia ·Ayami Yoshimi, Peter Bader, Susanne Matthes‐Martin, Jan Starý, Petr Sedláček, Ulrich Duffner, Thomas Klingebiel, Dagmar Dilloo, Wolfgang Holter, F Zintl, Bernhard Kremens, K-W Sykora, Christian Urban, Henrik Hasle, Elisabeth T Korthof, Tom Révész, Alexandra Fischer, Peter Nöllke, Franco Locatelli, Charlotte M. Niemeyer, (unknown)	2005	58
14	Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre‐emptive immunotherapy British Journal of Haematology ·Peter Bader, Charlotte M. Niemeyer, André Willasch, Hermann Kreyenberg, Brigitte Strahm, Bernhard Kremens, Bernd Gruhn, Dagmar Dilloo, Josef Vormoor, Peter Lang, D. Niethammer, Thomas Klingebiel, James F. Beck	2005	28
15	Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia Gene Therapy ·Andree Zibert, POR L. A. MARTINEZ CACHERO, Lena Müller, Naomi Fleury, T GREENWAY, Cornel Fraefel, Marie Roskrow, Roland Meisel, Dagmar Dilloo	2005	7
16	Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective Bone Marrow Transplantation ·Peter Bader, Hermann Kreyenberg, W Hoelle, Gregor Dueckers, Bernhard Kremens, Dagmar Dilloo, K-W Sykora, C. Niemeyer, Dirk Reinhardt, Josef Vormoor, Bernd Gruhn, Peter Lang, Johann Greil, Rupert Handgretinger, D Niethammer, Thomas Klingebiel, James F. Beck	2004	74
17	Immunosuppressive therapy for children with refractory anemia mediaTUM (Technical University of Munich) ·赵志荀, Irith Baumann, Brigitte Strahm, David Alvira Baeza, Eva Bergstraesser, S. Burdach, Dagmar Dilloo, Silvia Fenu, Triasmoro Larasistris, Thomas Klingebiel, E. Koscielniak, Karl Welte, Ikdam Blouza, 明美上田, CM Niemeyer	2003	1
18	Increased Transduction Efficiency of Primary Hematopoietic Cells by Physical Colocalization of Retrovirus and Target Cells Journal of Hematotherapy ·Jiahao Li, Koichi Moriwaki, Dagmar Dilloo, Thomas Hoffmann, Yuichi Bessho, Hans Erik Johnsen, Malcolm K. Brenner, Helen E. Heslop	1998	9
19	Gene Marking and Gene Therapy for Transplantation Medicine Journal of Hematotherapy ·Dagmar Dilloo, Donna Rill, Michael E. Grossmann, Thasia Leimig, Malcolm K. Brenner	1996	5
20	Combined chemokine and cytokine gene transfer enhances antitumor immunity Nature Medicine ·Dagmar Dilloo, Kevin B. Bacon, William T. Holden, Wanyun Zhong, Stefan Burdach, Albert Zlotnik, Malcolm K. Brenner	1996	167

About Dagmar Dilloo

Dagmar Dilloo is a scholar working on Hematology, Genetics, Immunology, Oncology and Public Health, Environmental and Occupational Health, having authored 92 papers that have together received 4.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (28 papers), Acute Lymphoblastic Leukemia research (18 papers), Immune Cell Function and Interaction (15 papers), Acute Myeloid Leukemia Research (12 papers), CAR-T cell therapy research (12 papers), Virus-based gene therapy research (11 papers), Immunotherapy and Immune Responses (9 papers) and Neuroblastoma Research and Treatments (9 papers). The work is most often cited by research in Genetics (1.5k citations), Hematology (1.1k citations), Immunology (1.4k citations), Oncology (1.4k citations) and Transplantation (81 citations). Dagmar Dilloo has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Roland Meisel, U. Göbel, Walter Däubener, Andree Zibert, M. D. Laryea, Helmut Hanenberg, Malcolm K. Brenner, Xiang Xiao, Kimikazu Hashino and David A. Williams. Their work appears in journals such as Blood, Bone Marrow Transplantation, British Journal of Haematology, Oncotarget and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact